Text Size:
Color Theme:

Company Information

Revenue, expenses and profitability over five years.

Income Statement

NOVARTIS INDIA LTD.

NSE Code
NOVARTINDEQ
BSE Code
500672
ISIN
INE234A01025
Industry
Pharmaceuticals
Financial Data

Income Statement

All amounts are in ₹ crore unless stated otherwise.

Showing Standalone data

Table can be scrolled horizontally on smaller screens.

Five-year standalone Income Statement for the selected company
ParticularsMar 26Mar 25Mar 24Mar 23Mar 22
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)PRARARARAR
FaceValue5.005.005.005.005.00
INCOME
Revenue From Operations [Net]354.33356.26334.04369.11387.57
Other Operating Revenues0.000.011.039.6312.30
Total Operating Revenues354.33356.27335.07378.74399.87
Other Income38.7741.9661.6858.1133.19
Total Revenue393.10398.23396.75436.85433.06
EXPENSES
Purchase Of Stock-In Trade210.58199.07189.98199.34187.26
Changes In Inventories Of FG,WIP And Stock-In Trade-12.213.759.862.35-9.13
Employee Benefit Expenses21.0818.7222.9635.64101.89
Finance Costs1.260.771.491.754.83
Provisions And Contingencies-0.13-0.170.170.370.00
Depreciation And Amortisation Expenses1.952.192.616.069.65
Other Expenses40.9143.4846.8475.9692.74
Total Expenses263.44267.81273.91321.47387.24
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax129.66130.42122.84115.3845.82
Exceptional Items0.000.000.000.00-49.64
Profit/Loss Before Tax129.66130.42122.84115.38-3.82
Tax Expenses-Continued Operations
Current Tax36.4829.9637.631.680.00
Deferred Tax0.00-0.440.0210.340.34
Tax For Earlier Years0.000.000.000.00-0.44
Total Tax Expenses36.4829.5237.6512.02-0.10
Profit/Loss After Tax And Before ExtraOrdinary Items93.18100.9085.19103.36-3.72
Profit/Loss From Continuing Operations93.18100.9085.19103.36-3.72
Profit/Loss For The Period93.18100.9085.19103.36-3.72
OTHER INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.)37.7440.8734.5041.86-1.51
Diluted EPS (Rs.)37.7440.8734.5041.86-1.51
DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend0.0061.73117.2824.6924.69
Equity Dividend Rate (%)0.00500.00500.00950.00200.00

Source: Financial statements as reported by the company.